BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q1 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $136,313,000 | +18.8% | 1,616,225 | +13.0% | 0.10% | +6.1% |
| Q4 2020 | $114,749,000 | +8.1% | 1,430,083 | +8.3% | 0.10% | -11.7% |
| Q3 2020 | $106,194,000 | -3.0% | 1,320,498 | +3.9% | 0.11% | -14.6% |
| Q2 2020 | $109,473,000 | +27.4% | 1,271,474 | +20.1% | 0.13% | -13.3% |
| Q1 2020 | $85,952,000 | -16.1% | 1,058,652 | -13.6% | 0.15% | +25.0% |
| Q4 2019 | $102,483,000 | -16.8% | 1,225,570 | -13.0% | 0.12% | -34.8% |
| Q3 2019 | $123,155,000 | +15.5% | 1,407,981 | +8.1% | 0.18% | +111.5% |
| Q2 2019 | $106,633,000 | -12.3% | 1,301,999 | -12.9% | 0.09% | -49.1% |
| Q1 2019 | $121,537,000 | +32.4% | 1,494,746 | +7.2% | 0.17% | +101.2% |
| Q4 2018 | $91,771,000 | -6.2% | 1,394,256 | +9.8% | 0.08% | -33.6% |
| Q3 2018 | $97,864,000 | +10.0% | 1,269,499 | +5.4% | 0.13% | 0.0% |
| Q2 2018 | $88,976,000 | +11.6% | 1,204,987 | -1.7% | 0.13% | 0.0% |
| Q1 2018 | $79,740,000 | +7.0% | 1,226,033 | +6.4% | 0.13% | +11.3% |
| Q4 2017 | $74,517,000 | +6730.2% | 1,152,780 | +7289.6% | 0.12% | +2775.0% |
| Q2 2015 | $1,091,000 | -96.9% | 15,600 | -97.1% | 0.00% | -97.2% |
| Q3 2013 | $35,350,000 | -20.8% | 538,124 | -16.5% | 0.14% | -23.1% |
| Q2 2013 | $44,637,000 | -7.4% | 644,399 | -10.8% | 0.19% | -8.4% |
| Q4 2012 | $48,182,000 | – | 722,796 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |